Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.96
Delayed Data
As of 10:43am ET
 -0.0276 / -0.92%
Today’s Change
1.93
Today|||52-Week Range
7.85
-6.64%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.99
Today’s open2.99
Day’s range2.96 - 2.99
Volume725
Average volume (3 months)90,041
Market cap$15.4M
Dividend yield--
Data as of 10:43am ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+35.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
CYANCyanotech Corp+0.11+3.39%
ATOSAtossa Genetics Inc+0.02+4.48%
ISRIsoRay Inc+0.01+1.58%
IBIOIbio Inc-0.00-0.70%
Data as of 11:45am ET, 06/23/2017

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$2.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts